nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—HTR1B—Serotonin receptors—HTR2A—conduct disorder	0.0473	0.0473	CbGpPWpGaD
Pindolol—ADRB3—Monoamine GPCRs—DRD4—conduct disorder	0.0433	0.0433	CbGpPWpGaD
Pindolol—ADRB3—Amine ligand-binding receptors—DRD4—conduct disorder	0.0364	0.0364	CbGpPWpGaD
Pindolol—HTR1A—Serotonin receptors—HTR2A—conduct disorder	0.036	0.036	CbGpPWpGaD
Pindolol—HTR1B—Monoamine GPCRs—DRD4—conduct disorder	0.0323	0.0323	CbGpPWpGaD
Pindolol—ADRB3—Monoamine GPCRs—HTR2A—conduct disorder	0.0282	0.0282	CbGpPWpGaD
Pindolol—HTR1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0271	0.0271	CbGpPWpGaD
Pindolol—ADRB3—G alpha (s) signalling events—CGA—conduct disorder	0.0268	0.0268	CbGpPWpGaD
Pindolol—ADRB1—Monoamine GPCRs—DRD4—conduct disorder	0.0257	0.0257	CbGpPWpGaD
Pindolol—ADRB2—Monoamine GPCRs—DRD4—conduct disorder	0.0251	0.0251	CbGpPWpGaD
Pindolol—HTR1A—Monoamine GPCRs—DRD4—conduct disorder	0.0246	0.0246	CbGpPWpGaD
Pindolol—ADRB3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0237	0.0237	CbGpPWpGaD
Pindolol—ADRB1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0228	0.0228	CbGpPWpGaD
Pindolol—ADRB1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0216	0.0216	CbGpPWpGaD
Pindolol—ADRB2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0211	0.0211	CbGpPWpGaD
Pindolol—HTR1B—Monoamine GPCRs—HTR2A—conduct disorder	0.021	0.021	CbGpPWpGaD
Pindolol—HTR1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0207	0.0207	CbGpPWpGaD
Pindolol—HTR1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0177	0.0177	CbGpPWpGaD
Pindolol—ADRB1—Monoamine GPCRs—HTR2A—conduct disorder	0.0168	0.0168	CbGpPWpGaD
Pindolol—ADRB2—Monoamine GPCRs—HTR2A—conduct disorder	0.0164	0.0164	CbGpPWpGaD
Pindolol—HTR1A—Monoamine GPCRs—HTR2A—conduct disorder	0.016	0.016	CbGpPWpGaD
Pindolol—ADRB1—G alpha (s) signalling events—CGA—conduct disorder	0.0159	0.0159	CbGpPWpGaD
Pindolol—ADRB2—G alpha (s) signalling events—CGA—conduct disorder	0.0156	0.0156	CbGpPWpGaD
Pindolol—ADRB1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0141	0.0141	CbGpPWpGaD
Pindolol—ADRB2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0138	0.0138	CbGpPWpGaD
Pindolol—HTR1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0135	0.0135	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0128	0.0128	CbGpPWpGaD
Pindolol—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0112	0.0112	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Other—DRD4—conduct disorder	0.0112	0.0112	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—CGA—conduct disorder	0.00973	0.00973	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00952	0.00952	CbGpPWpGaD
Pindolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00835	0.00835	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00758	0.00758	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00754	0.00754	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00742	0.00742	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Other—HTR2A—conduct disorder	0.00728	0.00728	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00725	0.00725	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—CGA—conduct disorder	0.00725	0.00725	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00716	0.00716	CbGpPWpGaD
Pindolol—HTR1B—G alpha (i) signalling events—DRD4—conduct disorder	0.00671	0.00671	CbGpPWpGaD
Pindolol—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00622	0.00622	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—CGA—conduct disorder	0.00577	0.00577	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00568	0.00568	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—CGA—conduct disorder	0.00565	0.00565	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.00552	0.00552	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—CGA—conduct disorder	0.0055	0.0055	CbGpPWpGaD
Pindolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00545	0.00545	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—DRD4—conduct disorder	0.00545	0.00545	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00533	0.00533	CbGpPWpGaD
Pindolol—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.00511	0.00511	CbGpPWpGaD
Pindolol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00506	0.00506	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—CGA—conduct disorder	0.00499	0.00499	CbGpPWpGaD
Pindolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00496	0.00496	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00485	0.00485	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00474	0.00474	CbGpPWpGaD
Pindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00467	0.00467	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00463	0.00463	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00425	0.00425	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00415	0.00415	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—CGA—conduct disorder	0.0041	0.0041	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00406	0.00406	CbGpPWpGaD
Pindolol—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00406	0.00406	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—DRD4—conduct disorder	0.00406	0.00406	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CGA—conduct disorder	0.00372	0.00372	CbGpPWpGaD
Pindolol—ADRB3—GPCR ligand binding—HTR2A—conduct disorder	0.00356	0.00356	CbGpPWpGaD
Pindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00348	0.00348	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—CGA—conduct disorder	0.00326	0.00326	CbGpPWpGaD
Pindolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00323	0.00323	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—DRD4—conduct disorder	0.00323	0.00323	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—CGA—conduct disorder	0.00319	0.00319	CbGpPWpGaD
Pindolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00316	0.00316	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—DRD4—conduct disorder	0.00316	0.00316	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.00312	0.00312	CbGpPWpGaD
Pindolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00309	0.00309	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.00309	0.00309	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—DRD4—conduct disorder	0.00308	0.00308	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CGA—conduct disorder	0.00296	0.00296	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CGA—conduct disorder	0.00295	0.00295	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CGA—conduct disorder	0.0029	0.0029	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.00283	0.00283	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—DRD4—conduct disorder	0.0028	0.0028	CbGpPWpGaD
Pindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00277	0.00277	CbGpPWpGaD
Pindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Pindolol—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00269	0.00269	CbGpPWpGaD
Pindolol—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00267	0.00267	CbGpPWpGaD
Pindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00265	0.00265	CbGpPWpGaD
Pindolol—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	0.00265	0.00265	CbGpPWpGaD
Pindolol—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00245	0.00245	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—WASF1—conduct disorder	0.00236	0.00236	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	0.00229	0.00229	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CGA—conduct disorder	0.0022	0.0022	CbGpPWpGaD
Pindolol—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	0.00211	0.00211	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—DRD4—conduct disorder	0.00208	0.00208	CbGpPWpGaD
Pindolol—ADRB2—GPCR ligand binding—HTR2A—conduct disorder	0.00206	0.00206	CbGpPWpGaD
Pindolol—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	0.00202	0.00202	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—HTR2A—conduct disorder	0.00201	0.00201	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	0.00183	0.00183	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—HTR2A—conduct disorder	0.00182	0.00182	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—DRD4—conduct disorder	0.00179	0.00179	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—WASF1—conduct disorder	0.00176	0.00176	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CGA—conduct disorder	0.00175	0.00175	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	0.00175	0.00175	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CGA—conduct disorder	0.00171	0.00171	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CGA—conduct disorder	0.00167	0.00167	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—DRD4—conduct disorder	0.00166	0.00166	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—DRD4—conduct disorder	0.00165	0.00165	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—DRD4—conduct disorder	0.00162	0.00162	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—DRD4—conduct disorder	0.00159	0.00159	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—WASF1—conduct disorder	0.0014	0.0014	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—WASF1—conduct disorder	0.00137	0.00137	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	0.00136	0.00136	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—WASF1—conduct disorder	0.00134	0.00134	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—DRD4—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	0.00119	0.00119	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—HTR2A—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	0.00114	0.00114	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	0.00108	0.00108	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HTR2A—conduct disorder	0.00108	0.00108	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HTR2A—conduct disorder	0.00106	0.00106	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	0.00104	0.00104	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CGA—conduct disorder	0.00103	0.00103	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—DRD4—conduct disorder	0.00098	0.00098	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—DRD4—conduct disorder	0.000959	0.000959	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—DRD4—conduct disorder	0.000938	0.000938	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HTR2A—conduct disorder	0.000803	0.000803	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HTR2A—conduct disorder	0.00064	0.00064	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HTR2A—conduct disorder	0.000626	0.000626	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HTR2A—conduct disorder	0.000612	0.000612	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EP300—conduct disorder	0.000571	0.000571	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—COMT—conduct disorder	0.000463	0.000463	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—MAOA—conduct disorder	0.00046	0.00046	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EP300—conduct disorder	0.000426	0.000426	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EP300—conduct disorder	0.000339	0.000339	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EP300—conduct disorder	0.000332	0.000332	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EP300—conduct disorder	0.000324	0.000324	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—EP300—conduct disorder	0.000199	0.000199	CbGpPWpGaD
